Literature DB >> 10321735

TC21 and Ras share indistinguishable transforming and differentiating activities.

S M Graham1, S M Oldham, C B Martin, J K Drugan, I E Zohn, S Campbell, C J Der.   

Abstract

Constitutively activated mutants of the Ras-related protein TC21/R-Ras2 cause tumorigenic transformation of NIH3T3 cells. However, unlike Ras, TC21 fails to bind to and activate the Raf-1 serine-threonine kinase. Thus, whereas Ras transformation is critically dependent on Raf-1 TC21 activity is promoted by activation of Raf-independent signaling pathways. In the present study, we have further compared the functions of Ras and TC21. First we determined the basis for the inability of TC21 to activate Raf-1. Whereas Ras can interact with the two distinct Ras-binding sequences in NH2-terminus of Raf-1, designated RBS1 and Raf-Cys, TC21 could only bind Raf-Cys. Thus, the inability of TC21 to bind to RBS1 may prevent it from promoting the translocation of Raf-1 to the plasma membrane. Second, we found that TC21 is an activator of the JNK and p38, but not ERK, mitogen-activated protein kinase cascades and that TC21 transforming activity was dependent on Rac function. Thus, like Ras, TC21 may activate a Rac/JNK pathway. Third, we determined if TC21 could cause the same biological consequences as Ras in three distinct cell types. Like Ras, activated TC21 caused transformation of RIE-1 rat intestinal epithelial cells and terminal differentiation of PC12 pheochromocytoma cells. Finally, activated TC21 blocked serum starvation-induced differentiation of C2 myoblasts, whereas dominant negative TC21 greatly accelerated this differentiation process. Therefore, TC21 and Ras share indistinguishable biological activities in all cell types that we have evaluated. These results support the importance of Raf-independent pathways in mediating the actions of Ras and TC21.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10321735     DOI: 10.1038/sj.onc.1202517

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.

Authors:  Pablo Rodriguez-Viciana; Celine Sabatier; Frank McCormick
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.

Authors:  Yline Capri; Elisabetta Flex; Oliver H F Krumbach; Giovanna Carpentieri; Serena Cecchetti; Christina Lißewski; Soheila Rezaei Adariani; Denny Schanze; Julia Brinkmann; Juliette Piard; Francesca Pantaleoni; Francesca R Lepri; Elaine Suk-Ying Goh; Karen Chong; Elliot Stieglitz; Julia Meyer; Alma Kuechler; Nuria C Bramswig; Stephanie Sacharow; Marion Strullu; Yoann Vial; Cédric Vignal; George Kensah; Goran Cuturilo; Neda S Kazemein Jasemi; Radovan Dvorsky; Kristin G Monaghan; Lisa M Vincent; Hélène Cavé; Alain Verloes; Mohammad R Ahmadian; Marco Tartaglia; Martin Zenker
Journal:  Am J Hum Genet       Date:  2019-05-23       Impact factor: 11.025

3.  Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis.

Authors:  Y Ohba; K Ikuta; A Ogura; J Matsuda; N Mochizuki; K Nagashima; K Kurokawa; B J Mayer; K Maki; J Miyazaki ; M Matsuda
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

4.  H-Ras, R-Ras, and TC21 differentially regulate ureteric bud cell branching morphogenesis.

Authors:  Ambra Pozzi; Sergio Coffa; Nada Bulus; Wenqin Zhu; Dong Chen; Xiwu Chen; Glenda Mernaugh; Yan Su; Songmin Cai; Amar Singh; Marcela Brissova; Roy Zent
Journal:  Mol Biol Cell       Date:  2006-02-08       Impact factor: 4.138

Review 5.  Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.

Authors:  James V Michael; Lawrence E Goldfinger
Journal:  Semin Cancer Biol       Date:  2017-12-02       Impact factor: 15.707

6.  ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potential.

Authors:  C Frémin; J-P Guégan; C Plutoni; J Mahaffey; M R Philips; G Emery; S Meloche
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

7.  R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System.

Authors:  Miriam Sanz-Rodriguez; Agnès Gruart; Juan Escudero-Ramirez; Fernando de Castro; José María Delgado-García; Francisco Wandosell; Beatriz Cubelos
Journal:  J Neurosci       Date:  2018-05-02       Impact factor: 6.167

8.  Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.

Authors:  Yuan Huang; Fatima Rangwala; Patricia C Fulkerson; Bo Ling; Erin Reed; Adrienne D Cox; John Kamholz; Nancy Ratner
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

9.  In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1.

Authors:  Deanna M Patmore; Sara Welch; Patricia C Fulkerson; Jianqiang Wu; Kwangmin Choi; David Eaves; Jennifer J Kordich; Margaret H Collins; Timothy P Cripe; Nancy Ratner
Journal:  Cancer Res       Date:  2012-08-23       Impact factor: 12.701

10.  siRNA-mediated downregulation of TC21 sensitizes esophageal cancer cells to cisplatin.

Authors:  Raghibul Hasan; Shyam Singh Chauhan; Rinu Sharma; Ranju Ralhan
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.